UAB "Renalfarma" Finance - revenue, profit
Financial ratios
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 2,053,315 |
| 342,219 |
| 154,130 |
| 131,571 |
| 21,929 |
| 37.20 |
| 6.41 |
| 356,905 |
| 275,860 |
| 104,683 |
| 525,517 |
| 2024 |
|---|
| 2,010,833 |
| 389,696 |
| 188,260 |
| 161,594 |
| 31,317 |
| 40.65 |
| 8.04 |
| 398,499 |
| 267,819 |
| 75,338 |
| 588,206 |
| 2025 |
|---|
| 2,451,901 |
| 490,380 |
| 347,696 |
| 292,898 |
| 58,580 |
| 42.76 |
| 11.95 |
| 441,398 |
| 479,039 |
| 46,037 |
| 872,215 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 2,451,901 |
| 490,380 |
| 347,696 |
| 292,898 |
| 58,580 |
| 42.76 |
| 11.95 |
| 441,398 |
| 479,039 |
| 46,037 |
| 872,215 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
2,451,901 €22 % *
Sales per employee (€)
490,380 €26 % *
Profit before tax (€)
347,696 €85 % *
Net Profit (€)
292,898 €81 % *
Profit per employee (€)
58,580 €87 % *
Total profitability (%)
42.76 %5.19 % *
Net profitability (%)
11.95 %48.63 % *
Equity (€)
441,398 €11 % *
Amounts Payable And Liabilities (€)
479,039 €79 % *
Non-current Assets (€)
46,037 €-39 % *
CurrentAssets (€)
872,215 €48 % *
